Patents by Inventor Kailash Prasad

Kailash Prasad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis of restenosis in patients undergoing percutaneous coronary intervention
    Patent number: 8546087
    Abstract: The present invention relates to compounds, compositions, methods and/or kits for determining and/or predicting and/or diagnosing and/or treating restenosis in a patient.
    Type: Grant
    Filed: June 2, 2010
    Date of Patent: October 1, 2013
    Assignee: University of Saskatchewan
    Inventor: Kailash Prasad
  • DIAGNOSIS OF RESTENOSIS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Publication number: 20120128660
    Abstract: The present invention relates to compounds, compositions, methods and/or kits for determining and/or predicting and/or diagnosing and/or treating restenosis in a patient.
    Type: Application
    Filed: June 2, 2010
    Publication date: May 24, 2012
    Applicant: UNIVERSITY OF SASKATCHEWAN
    Inventor: Kailash Prasad
  • Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis
    Publication number: 20080009449
    Abstract: A method of treating hypercholesterolemic atherosclerosis in a mammal exhibiting symptoms of the disease. The method comprises administering to the mammal an effective amount of a lignan complex derived from flax and containing about 34 to 38% by weight of secoisolariciresinol diglucoside. The invention also relates to compositions and uses of the complex suitable for the treatment of the disease and related conditions.
    Type: Application
    Filed: July 7, 2006
    Publication date: January 10, 2008
    Inventor: Kailash Prasad
  • Lignan complex derived from flaxseed as hypercholesterolemic and anti-atherosclerotic agent
    Patent number: 6673773
    Abstract: A method is described for treating hypercholesterolemic atherosclerosis or for reducing total cholesterol while raising high-density lipoportoein cholesterol. It involves administering to a patient a substantially pure complex derived from flaxseed and containing secoisolariciresinol diglucoside (SDG), cinnamic acid glucosides and hydroxymethyl glutaric acid.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: January 6, 2004
    Assignee: University of Saskatchewan Technologies Incorporated
    Inventor: Kailash Prasad
  • LIGNAN COMPLEX DERIVED FROM FLAXSEED AS HYPERCHOLESTEROLEMIC AND ANTI-ATHEROSCLEROTIC AGENT
    Publication number: 20030212007
    Abstract: A method is described for treating hypercholesterolemic atherosclerosis or for reducing total cholesterol while raising high-density lipoportoein cholesterol. It involves administering to a patient a substantially pure complex derived from flaxseed and containing secoisolariciresinol diglucoside (SDG), cinnamic acid glucosides and hydroxymethyl glutaric acid.
    Type: Application
    Filed: May 10, 2002
    Publication date: November 13, 2003
    Inventor: Kailash Prasad
  • Use of purified SDG as a hypotensive (vasodilator) agent
    Patent number: 6498145
    Abstract: The compound secoisolariciresinol diglucoside (SDG), obtained from flaxseed is used for treating hypertension or for reducing or preventing the development of elevated blood pressure in humans or animals. These uses include the treatment of ischemic heart disease, heart failure and intermittent claudication.
    Type: Grant
    Filed: June 14, 2000
    Date of Patent: December 24, 2002
    Assignee: University of Saskatchewan Technologies Incorporated
    Inventor: Kailash Prasad
  • Antioxidant activity in SDG metabolites
    Patent number: 6486126
    Abstract: The compounds secoisolariciresinol (SECO), enterodiol (ED) and enterolactone (EL), which are metabolites of secoisolariciresinol diglucoside obtained from flaxseed, are used for the treatment of diseases or conditions requiring administration of an antioxidant. Diseases or conditions that may be treated include hypercholesterolemic atherosclerosis, type I and type II diabetes, ischemic heart disease, heart failure, endotoxic and hemmorhagic shock, inflammatory bowel disease, rheumatoid arthritis, Parkinson's disease, and stroke.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: November 26, 2002
    Assignee: University of Saskatchewan Technologies Incorporated
    Inventor: Kailash Prasad
  • Purified SDG as an antioxidant
    Patent number: 5846944
    Abstract: The compound secoisolariciresinal diglucoside (SDG), obtained from flaxseed is used for reducing or preventing the development of hypercholesterolemic atherosclerosis and for reducing total cholesterol in humans or animals. It is also used for treating diabetes mellitus.
    Type: Grant
    Filed: April 3, 1997
    Date of Patent: December 8, 1998
    Assignee: The University of Saskatchewan
    Inventor: Kailash Prasad
  • Lignan complex derived from flaxseed as hypercholesterolemic and anti-atherosclerotic agent
    Patent number: RE40837
    Abstract: A method is described for treating hypercholesterolemic atherosclerosis or for reducing total cholesterol while raising high-density lipoportoein cholesterol. It involves administering to a patient a substantially pure complex derived from flaxseed and containing secoisolariciresinol diglucoside (SDG), cinnamic acid glucosides and hydroxymethyl glutaric acid.
    Type: Grant
    Filed: December 29, 2005
    Date of Patent: July 7, 2009
    Assignee: Archer-Daniels-Midland Company
    Inventor: Kailash Prasad